Home  »  Stock   »  Enzo Biochem Inc. (ENZ) is offering a Buy-In Oppor...

Enzo Biochem Inc. (ENZ) is offering a Buy-In Opportunity

Enzo Biochem Inc. (ENZ) is priced at $1.19 after the most recent trading session. At the very opening of the session, the stock price was $1.03 and reached a high price of $1.19, prior to closing the session it reached the value of $1.00. The stock touched a low price of $1.0081.Recently in News on March 16, 2023, Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp. Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. You can read further details here

Enzo Biochem Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.1900 on 03/18/22, with the lowest value was $1.0000 for the same time period, recorded on 03/15/23.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Enzo Biochem Inc. (ENZ) full year performance was -60.86%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Enzo Biochem Inc. shares are logging -62.70% during the 52-week period from high price, and 19.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.00 and $3.19.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 65568 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Enzo Biochem Inc. (ENZ) recorded performance in the market was -16.78%, having the revenues showcasing -15.00% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 60.57M, as it employees total of 465 workers.

The Analysts eye on Enzo Biochem Inc. (ENZ)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.5929, with a change in the price was noted -1.03. In a similar fashion, Enzo Biochem Inc. posted a movement of -46.40% for the period of last 100 days, recording 92,781 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ENZ is recording 0.10 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.09.

Technical rundown of Enzo Biochem Inc. (ENZ)

Raw Stochastic average of Enzo Biochem Inc. in the period of last 50 days is set at 28.79%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 54.29%. In the last 20 days, the company’s Stochastic %K was 28.34% and its Stochastic %D was recorded 23.45%.

Considering, the past performance of Enzo Biochem Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -16.78%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -45.91%, alongside a downfall of -60.86% for the period of the last 12 months. The shares increased approximately by 2.59% in the 7-day charts and went up by -9.16% in the period of the last 30 days. Common stock shares were lifted by -15.00% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts